Citigroup
OM icon

Citigroup’s Outset Medical OM Stock Holding History

Citigroup’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.16K Buy
822
+450
+121% +$1.84K ﹤0.01% 5357
2025
Q4 		$1.38K Sell
372
-33
-8% -$283 ﹤0.01% 5507
2025
Q3 		$5.72K Sell
405
-7,544
-95% -$118K ﹤0.01% 5199
2025
Q2 		$153K Buy
7,949
+7,944
+158,880% +$124K ﹤0.01% 4191
2025
Q1 		$55 Sell
5
-88
-95% -$1.05K ﹤0.01% 5448
2024
Q4 		$1.54K Buy
93
+78
+520% +$974 ﹤0.01% 5563
2024
Q3 		$152 Sell
15
-1,405
-99% -$41.8K ﹤0.01% 5523
2024
Q2 		$82K Buy
1,420
+863
+155% +$42.3K ﹤0.01% 4316
2024
Q1 		$18.5K Sell
557
-1,544
-73% -$78.2K ﹤0.01% 5053
2023
Q4 		$170K Buy
2,101
+1,958
+1,369% +$159K ﹤0.01% 3985
2023
Q3 		$23.3K Sell
143
-1,047
-88% -$247K ﹤0.01% 4363
2023
Q2 		$390K Buy
1,190
+989
+492% +$302K ﹤0.01% 3541
2023
Q1 		$55.5K Buy
201
+7
+4% +$2.57K ﹤0.01% 4227
2022
Q4 		$75.3K Sell
194
-57
-23% -$16.1K ﹤0.01% 4134
2022
Q3 		$60K Sell
251
-165
-40% -$44.2K ﹤0.01% 4310
2022
Q2 		$93K Buy
416
+73
+21% +$31.4K ﹤0.01% 4254
2022
Q1 		$234K Sell
343
-1,344
-80% -$809K ﹤0.01% 4000
2021
Q4 		$1.17M Sell
1,687
-14
-0.8% -$10.4K ﹤0.01% 3091
2021
Q3 		$1.26M Buy
1,701
+1,505
+768% +$1.03M ﹤0.01% 2906
2021
Q2 		$147K Sell
196
-1,715
-90% -$1.31M ﹤0.01% 4370
2021
Q1 		$1.56M Buy
1,911
+1,785
+1,417% +$1.38M ﹤0.01% 2660
2020
Q4 		$107K Buy
+126
New +$97.1K ﹤0.01% 5485

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citigroup's OM Position: Q1 2026 in Review

Citigroup increased its Outset Medical (OM) stake by 121% in Q1 2026, buying an estimated $1.84K and bringing the position to 822 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #5357.

Citigroup first reported a position in OM in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.56M in Q1 2021. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Citigroup held 822 shares of Outset Medical worth $3.16K as of Q1 2026.
  • Citigroup bought 450 Outset Medical shares in Q1 2026, an estimated $1.84K.
  • Outset Medical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5357 holding.
  • Citigroup first reported a position in Outset Medical in Q4 2020 and has held it in 22 quarters since.
  • Citigroup's Outset Medical position peaked at $1.56M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.